Catherine Pickering is leading iOnctura, which is focused on solving the problem of cancer resistance both at the tumor and around its environment

from Biotech CEO Sisterhood · host BiotechTV

She discusses the approach and the company's lead program, which targets PI3Kδ. Plus, and autotaxin program for cancer and TGF-β.

Episode metadata supplied by the publisher feed · Published Sep 5, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Catherine Pickering is leading iOnctura, which is focused on solving the problem of cancer resistance both at the tumor and around its environment

0:00 13:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on September 5, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!